Quris AI
Artificial Intelligence · E-learning
Overview
Quris AI is tackling the most impactful AI challenge of our time: Predicting which drug candidates will safely work in humans. Quris’s machine-learning bio-platform predicts which drug candidates will safely work in humans.
Funding and backers
Total raised
$28M
1 round on record
Latest round
$28M
Venture round · Jan 2022 · 4 yr ago
Backers
1
Vox Capital
The money's age
Long since its last round
58 months since the last round · not hiring
Momentum
15/100
in the news
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Tractionpublic signals, read monthly
Web presence
top 7%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Jan 2022 | $28M | — | www.israelhayom.com |
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Axon is an interactive AI platform that accelerates drug discovery by amplifying the utility of cheminformatics, physics-based simulation…
InterAx Biotech integrates experimental and computational pharmacology to reveal critical properties of novel GPCR drug candidates. Work…
Big Data Federation, Inc. is an artificial intelligence-driven financial technology company which develops and applies innovative…
Delfos is a Brazilian company founded in 2018 that applies machine learning to renewable energy assets. Its platform predicts failures and…
Pictura Bio, Oxford based med-tech company, delivering one-minute diagnostics to transform healthcare. Proprietary hardware, and machine…
Generating a chemical atlas for treating human disease. Our ATLAS technology merges AcTive® Learning with Automated Synthesis and…
Financials
Total raised
$28M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2022 | $28M | Details |
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Vox CapitalVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
Merck KGaA, Quris-AI Extend Current Collaboration PharmExec
Deal comes amid first successful partnership.
Read more
Report
Report
Quris-AI Acquires Nortis to Enhance Bio-AI Platform - M&A
Quris-AI acquires Nortis to enhance its Bio-AI platform with Kidney-on-Chip technology, improving drug safety prediction and accelerating...
Read more
Report
Merck KGaA, Darmstadt, Germany and Quris-AI Expand Collaboration
Companies Extend Collaboration After Successful Preclinical Study Assessed the Quris-AI BioAI Drug Safety PlatformBOSTON and TEL AVIV, Israel, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Quris-AI, an artificial intelligence (AI) innovator disrupting the pharmaceut
Read more
Report
Quris-AI: How This Company Is Redefining Drug Development Using AI/ML
Quris-AI is an artificial intelligence company that is disrupting drug development and its machine-learning bio-platform better predicts which drug candidates will safely work in humans, avoiding major costs of failed clinical trials. To learn more about
Read more
Report
Merck will assess Quris' AI 'patient-on-a-chip' drug safety tech
German drugmaker Merck KGaA has reached an agreement to pilot an artificial intelligence platform developed by Quris that aims to identify potential safety problems with new therapeutic candidates as early as possible in the drug discovery process. Quris'
Read more
Report
Health tech startup Quris AI raises $28M
Israeli health tech startup Quris AI, which uses artificial intelligence (AI) to develop drugs, has added another $19 million to its seed funding round, bringing in a total of $28 million in seed funding, the company announced Tuesday. Follow Israel Hayom
Read more
Report
Quris combines AI with 'patient on a chip' to speed drug development and reduce animal testing
The necessity of animal testing is a sad one for the process of drug discovery, but there's seemingly no good alternative to mice, even though they're not
Read more
Report
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Tel Aviv
Israel
HQ
114 Yigal Alon Street, Tel Aviv-Yafo, IL